Skip to content
Vanity or Vice

Evidence Index

Keep the receipt attached to the claim.

Regulatory language, ingredient evidence, finished-product proof, mechanism, uncertainty, and the gap between scientific atmosphere and decision-grade support.

The examination

The right evidence has to support the exact decision being sold.

Claims and Evidence identifies the evidence object, checks whether research transfers to the marketed product or procedure, watches the net impression of language and imagery, and keeps uncertainty explicit.

Choose the next useful question

Glamour stays. The evidence gets a seat.

02

Research method

Inspect the standard

See how source type, date, population, formulation, and limitations are handled.

Inspect the standard →

What remains visible

Desire, evidence, burden and the work still owed.

The working file

Depth below the map.

The map gets you oriented. The deeper files keep the sources, limitations, tools, and practical details close enough to use when the decision stops being theoretical.

A claim is not evidence, and a citation is not a claim. Most beauty marketing fails somewhere in the gap between the two: the study is real, the ingredient is real, and neither one was tested in the bottle you are being sold.

That gap is the entire job here. What was the evidence object — an ingredient, a finished formula, a device category, or the exact model in the room? Does the research transfer to the thing actually being sold? What does the whole page imply that no single sentence commits to? And what is still unknown, said out loud, rather than quietly rounded up.

I care about that gap because I have wanted the breakthrough too. I have bought the beautiful product, booked the promising treatment, known enough to ask better questions and occasionally failed to ask them anyway. Evidence is not here to punish the wanting. It is here to keep the wanting from writing its own footnotes.

That also means the answer is allowed to move. Better data can change a verdict. A failed real-world test can change my enthusiasm very quickly. Certainty is not the house style; paying attention is.

The instruments on this desk

The long form is How to Take a Claim Apart. Eight passes, about eleven minutes, and every verdict and register entry on this site is reasoned out of it. Where a shorter version of the method turns up elsewhere on the site, that page is a summary and this one is the standard.

The rest are the fast versions, for when you are standing in a shop with a box in your hand. The Claim Test takes one sentence apart and shows what the wording actually commits to. The Fine Print handles the six phrases doing most of the persuading — hypoallergenic, cosmeceutical, FDA approved, clinically proven, dermatologist tested, for sensitive skin — and what each is worth in the United States, which is generally less than the packaging implies. Proof, Please makes you name the kind of evidence you are holding before you ask it to carry a conclusion it was never built for. And Same Picture? is the one people resist, because a before-and-after that has quietly changed its lighting, distance and expression has already finished persuading you before you looked at the skin.

When the decision is too expensive to make standing up, the Product Evidence Receipt is the printable version: the finished formula beside the claim, the comparator beside the price, and a blank line for what the premium is demonstrably buying.

Keep the study attached to the people in it. Use the Evidence Population Receipt when the claim travels farther than the cohort.

Next move

Keep the next decision inspectable.

Start with the exact wording. Most beauty decisions get easier once the sentence doing the selling is held still and read properly.

Open the Claim Decoder →

The claim files · 158

Every claim held still and checked.

More files in this section
  1. The Face After Fast Weight Loss: What the ‘Ozempic Face’ Headline Gets Wrong
  2. Collagen Masks Are 2026’s Hydration Trend. Your Face Is Not Absorbing a New Dermis.
  3. PRP and PRF Both Start With Your Blood. They Do Not End With the Same Preparation.
  4. ‘Brightening’ Is Not a Diagnosis. Your Pigment Ingredient Still Needs a Job.
  5. ‘Baby Botox’ Is a Dose Strategy, Not a Cheaper Version of Botox
  6. Oxygenetix Says “Breathable.” The Useful Question Is What the Foundation Actually Does.
  7. Profhilo Is Not Filler. In the U.S., It Is Also Not an FDA-Approved Shortcut.
  8. PRF Under Eyes: What It Can Improve, and What ‘Natural Filler’ Gets Wrong
  9. Your Mineral Foundation Has SPF. That Does Not Make It Your Sunscreen.
  10. What ‘Non-Comedogenic’ Can—and Cannot—Tell You About a Foundation
  11. EWG’s Skin Deep Score Looks Like a Lab Result. The Dose Never Made It Into the Formula.
  12. Serum Foundation: Skincare-Infused Makeup Still Has to Be Good Makeup
  13. Cryotherapy and Cold Plunges Both Make You Cold. That Does Not Make Them the Same Treatment.
  14. Copper Peptides, Retinoids, and Vitamin C: Your Routine Does Not Need a Peace Treaty
  15. Slugging Is Petrolatum With Better Public Relations
  16. The Viscosity Test: What Texture Can and Cannot Tell You About a Formula
  17. Three Zincs, Three Different Jobs
  18. Filler Migration and Dissolving: Ask About the Exit Before the Entrance
  19. NAD+ Drips Have a Fantastic Mechanism Story and Almost No IV Outcomes Story
  20. Essential Oils Are Natural. Your Skin Still Gets to Object.
  21. Iron Oxides Are Doing More for Melasma Than the “Brightening” Claim
  22. Packaging Is Evidence, Just Not the Evidence You Think
  23. Clean Mascara, Flaking, and the Preservation Myth
  24. ‘Responsibly Sourced Mica’ Is a Promise. Ask What the Brand Can Trace.
  25. The Label Says Clean. Your Skin Still Has Questions.
  26. HydraFacial Does More Than Put Serum on Your Face. That Still Does Not Make It Magic.
  27. Why Mineral Makeup Sometimes Itches—and Why Bismuth Gets the Blame
  28. Marini SkinSolutions Skin Care Management System Has Logic. Your Routine Still Gets to Edit It.
  29. Event-Ready Beauty Claims: Read the Promise Before You Book
  30. The Shark Question Hiding Inside Squalane
  31. Jan Marini Is Now Marini SkinSolutions. The System Still Has to Prove More Than Good Taste.
  32. ‘Preservative-Free’ Skincare Still Has to Survive Your Bathroom
  33. Bemotrizinol Made It Through. Four Things It Still Does Not Fix.
  34. Korean Sunscreen Won the Headline. Three Backs Is Not a Verdict.
  35. Where Skin-Benefiting Makeup Stops Being Makeup
  36. Lymphatic Drainage Is a Real Technique. ‘Detox Massage’ Is Doing Too Much With It.
  37. ‘Talc-Free’ Solves a Marketing Problem. The Real Talc Question Is Asbestos Testing.
  38. Lead in Lipstick: The Chain Email Was Scarier Than the FDA Data
  39. A Pile of Studies Is Not a Verdict: How to Audit a Beauty Evidence Stack
  40. IV Vitamin Drips Bypass Your Gut. That Is Not the Same Thing as Needing Them.
  41. Fragrance-Free, Unscented, and the Label Gap
  42. How to Use Vanity or Vice Before You Buy, Book, or Believe the Claim
  43. The Meta-Analysis of Dermoscopy Criteria Excluded Nail, Acral and Facial Melanoma
  44. The LED Is Part of the Problem, and That Part Already Has a Fix
  45. A Scarring Bald Patch That Is Sometimes a Lung Disease
  46. Thirteen Percent of the School Had It. Every One of Them Was Black.
  47. Two Studies Say the Neck Tells You Something. Two Say It Only Tells You the BMI.
  48. Six Trials, 198 People, and Nobody Recorded How Long It Took to Heal
  49. Porosity Is Real, It Is Eight Nanometers Wide, and It Is Damage
  50. The Standard Gene Panel Looks for Four Mutations. Sequencing the Whole Gene Found Nine.
  51. The Mark Left Behind Tracked Quality of Life Better Than the Disease Did
  52. The Dark-Skin Images Are the Infections
  53. Same Senior Author, Nineteen Years Apart, Opposite Verdicts
  54. A Task Force Flagged This in 1995. The Definition Still Leads With Redness.
  55. The Most-Cited Case in This Field Has No Medical Record
  56. Seventy-Seven Percent, Attributed to a Paper That Does Not Contain It
  57. The Reference Cohort Is 490 People and Records Nobody’s Race
  58. Sixteen Strokes a Day, Measured on the Wrong Heads
  59. Nobody Has Ever Checked Whether Two People Agree on 4C
  60. The Instrument Has Existed Since 1991. Nobody Has Pointed It at the Shelf.
  61. Twenty-Two Patients in Fourteen Years
  62. The Gap Is Getting Wider, and It Is Getting Wider in Early-Stage Disease
  63. Seven Times Faster Than Anticipated
  64. Eighty-Nine Percent of the Benefit Arrives With the First Wash of the Week
  65. Fragrance Allergy Was Nearly Twice as Common in the White Patients
  66. Five Point Four Times the Incidence, and Nobody Has Counted the Delay
  67. Roughly One in 190, and Ten Years to Get the Name
  68. It Grows. It Just Does Not Stay.
  69. The Rule Has Been Coming for Three Years and Has Never Been Written
  70. Median pH 12.36. Every Single One Was Over the Corrosive Line.
  71. Nobody Biopsied Anyone. The Number Is Still Everywhere.
  72. Most of It Is Supposed to Be There
  73. Faces Do Not All Fall the Same Way
  74. No Diagnostic Criteria, No Treatment Guidelines, Twenty Men to Every Woman
  75. It Does Not Look Greasy. It Looks Like Pale Petals.
  76. 1.39 Millimeters Against 1.41. That Is the Whole Difference.
  77. “Dermatologist Tested” Means a Dermatologist Was There
  78. Forty Days for the Mole, Twenty-Two for the Botox
  79. The AI Made the Gap Worse
  80. Two Years In, Two Thirds Got Their Faces Back
  81. Seen by the Dermatologist. Not Given the Drug.
  82. The Eczema Severity Score Is Mostly Measuring Redness
  83. Two Percent of Rosacea Diagnoses. That Is an Undercount, Not a Prevalence.
  84. Abnormal Starts at Two If You Are Asian and Nine If You Are Greek
  85. “Shave Closer” Is Exactly Backwards
  86. Coconut Oil Is the Only One With a Mechanism, and It Was Not Measuring Growth
  87. The Relaxer Study Everyone Quoted Was 85.6 Percent White
  88. “Hot Comb Alopecia” Is a Name That Outlived Its Evidence
  89. 8.6 Percent in the First Year of School. 21.7 by the Last.
  90. Your Skin Has Already Run the Test
  91. Six Types, and the First Four Were All White Skin
  92. Ten Years of Not Having Surgery Costs Roughly What the Surgery Costs
  93. Stop Everything Tomorrow. Here Is What You Would Still Have.
  94. Seven Diodes or Three Hundred and Four: Nobody Has Compared Two Laser Caps
  95. Acid Versus Acid: The Percentage on the Front Is the Least Useful Number on the Bottle
  96. UltraClear Is Seven Different Appointments Wearing One Name
  97. Medicube Booster Pro X2: Seven Modes Are Not Seven Clinical Trials
  98. The Roller and the Pen Share a Word and Almost Nothing Else
  99. Most Bloated Routines Are Four Good Products and Five Duplicates
  100. The Three-Year Number: What Four Routes to the Same Face Actually Cost
  101. Buying an LED Mask Means Buying Forty-Three Hours a Year
  102. Product Category Intelligence: Shop the Job Before You Shop the Brand
  103. Ingredient-List Literacy: What the Label Can and Cannot Tell You
  104. Ceramides Are Not Moisture. They Are Part of the Barrier Architecture.
  105. NAD+ Skincare: Longevity Language Arrived Before the Finished-Product Evidence
  106. Ectoin Has Randomized Human Trials Behind It. It Still Does Not Need a Throne.
  107. Which Beta-Glucan Is Actually in the Bottle?
  108. Volufiline’s Strongest Human Data Came From a Breast Study, Not a Face
  109. Beef Tallow Makes a Good Balm and a Bad Argument
  110. Topical Tranexamic Acid Has Four Trials and They Do Not Agree
  111. Glycolic Acid Improved Texture and Tone. The Wrinkle Result Missed Significance.
  112. Bakuchiol’s Case Rests on Forty-Four People and Twelve Weeks
  113. The Acne Trial People Quote About Hypochlorous Acid Studied a Different Molecule
  114. Azelaic Acid Has Forty-Three Trials. Your Serum May Not Be in Any of Them.
  115. MOTS-c Wants Credit for Your Workout
  116. Semax Sells More Certainty Than It Can Back
  117. What Melanotan II Costs Besides Money
  118. Why the CJC-1295 and Ipamorelin Stack Keeps Its Numbers Vague
  119. TB-500 and the Comeback Photograph
  120. Spermidine Is a Watchlist, Not a Purchase
  121. Resveratrol Became an Anti-Aging Icon Before the Human Outcomes Caught Up
  122. Curcumin’s Absorption Problem Is Real. So Is the Liver-Safety Footnote.
  123. BPC-157 Heals Rats Beautifully
  124. CoQ10 Raises the Level. A 2026 Trial Asked Whether Mitochondria Noticed.
  125. Retatrutide: A Phase 3 Drug Is Not a Product Yet
  126. What NMN and NR Buy You Is a Higher Blood Metabolite
  127. Fish Oil Is Not One Thing: Omega-3s, Biological Aging, and the Anti-Aging Shortcut
  128. Magnesium Is Essential. That Does Not Make Every Longevity Claim Essential.
  129. The Skinny Shot Story Is Smaller Than Semaglutide
  130. Vitamin D Is a Deficiency Question Before It Is a Longevity Strategy
  131. Which Tirzepatide Are You Actually Buying?
  132. Collagen Peptides and Skin Aging: The Industry-Funding Problem Inside the Meta-Analyses
  133. Ten Supplements Sold as Longevity, and What Each One Was Measured Doing
  134. Creatine for Women: What the Evidence Supports, and Where the Longevity Marketing Gets Ahead of It
  135. Before-and-After Culture: What the Photo Cannot Prove
  136. What the Marketing Photograph Crops Out
  137. ZO Growth Factor Serum Has New Data. ‘Six Years Younger’ Still Needs Translation.
  138. GHK-Cu, One Copper Peptide With Two Evidence Files
  139. The Word Peptide Is Doing Too Much Work
  140. One Titanium Dioxide Opinion Cleared a Loose Powder and Refused a Hairspray
  141. Colorescience Earned the SPF Reputation. The Brush Still Needs Enough Product.
  142. Mineral Makeup’s Purity Story Is Shorter Than Its Ingredient List
  143. A White Coat Is Not a Regulatory Category: What ‘Medical-Grade’ Makeup Actually Means
  144. One More Thing Wrong With Your Face
  145. Before You Book #3: An Energy Device Without Parameters Is Just Atmosphere
  146. Claims Literacy #4: Growth Factors, PDRN, and the Route the Bottle Quietly Drops
  147. Claims Literacy #2: ‘Clinically Tested’ Names a Room. ‘Clinically Proven’ Owes You a Study.
  148. The Exosome Bottle Will Not Tell You What Is In It
  149. A Skincare Percentage Is a Measurement Pretending to Be a Score
  150. ‘Medical Grade’ Is a Marketing Category, Not a Verdict
  151. FDA Cleared, Approved, Registered: These Words Are Not Interchangeable
  152. Where Beauty Meets Better Judgment: The Vanity or Vice Method
  153. Beauty Evidence Has Levels. Ingredient Research Is Not Finished-Product Proof.
  154. How to Read a Beauty Claim Before You Trust It